Pepdox
Studies
Peptides
Calculator
Orforglipron (Foundayo) - a second oral GLP-1 receptor agonist for weight loss. | Pepdox
Home
/
Search
/
PMID 42139026
Orforglipron (Foundayo) - a second oral GLP-1 receptor agonist for weight loss.
The Medical letter on drugs and therapeutics
2026
PMID: 42139026
View on PubMed
DOI: 10.58347/tml.2026.1755a
Semaglutide
Keywords
Foundayo
Wegovy
adverse effects
dosage
drug interactions
efficacy
lactation
orforglipron
pregnancy
safety
semaglutide
weight loss